0001590934-17-000001.txt : 20170515 0001590934-17-000001.hdr.sgml : 20170515 20170515131540 ACCESSION NUMBER: 0001590934-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170515 DATE AS OF CHANGE: 20170515 EFFECTIVENESS DATE: 20170515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oricula Therapeutics LLC CENTRAL INDEX KEY: 0001590934 IRS NUMBER: 461984834 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-286733 FILM NUMBER: 17842892 BUSINESS ADDRESS: STREET 1: 474 39TH AVENUE EAST CITY: SEATTLE STATE: WA ZIP: 98112 BUSINESS PHONE: 206-322-7526 MAIL ADDRESS: STREET 1: 474 39TH AVENUE EAST CITY: SEATTLE STATE: WA ZIP: 98112 D 1 primary_doc.xml X0707 D LIVE 0001590934 Oricula Therapeutics LLC 474 39TH AVENUE EAST SEATTLE WA WASHINGTON 98112 206-322-7526 DELAWARE None None Limited Liability Company true 2013 Malcolm Gleser 474 39th Avenue E Seattle WA WASHINGTON 98112 Executive Officer Director Promoter Ed Rubel 474 39th Avenue E Seattle WA WASHINGTON 98112 Director Promoter Vince Groppi 474 39th Avenue E Seattle WA WASHINGTON 98112 Director Promoter Other Decline to Disclose 06b false 2017-05-12 false true false 0 400000 25000 375000 false 1 0 0 0 false Oricula Therapeutics LLC Malcolm Gleser Malcolm Gleser CEO 2017-05-15